Search
Suvodirsen
go.drugbank.com/drugs/DB17940InvestigationalSuvodirsen is an antisense oligonucleotide that has been investigated for the treatment of Duchenne muscular dystrophy.
CTX110
go.drugbank.com/drugs/DB18626InvestigationalCTX110 is an allogeneic CRISPR/Cas9-mediated genetically modified CAR T cell therapy targeting CD19 antigen.
REM-422
go.drugbank.com/drugs/DB19304InvestigationalREM-422 is an orally bioavailable, small molecule mRNA degrader of the proto-oncogene c-Myb.
AEM-28-14
go.drugbank.com/drugs/DB17643ExperimentalAEM-28-14 is an analog of [AEM-28], an apolipoprotein E mimetic peptide, with a 400 percent greater cholesterol-lowering efficacy and a several-fold increase in drug tolerability.
DTX-101
go.drugbank.com/drugs/DB17699InvestigationalDTX-101 is an investigational gene therapy consisting of an adeno-associated virus serotype Rh10 vector encoding the human Factor Ix gene.
Fluorfenidine F-18
go.drugbank.com/drugs/DB19557ExperimentalFluorfenidine F-18 has a monoisotopic molecular weight of 382.07 Da.
Crobenetine
go.drugbank.com/drugs/DB21095InvestigationalCrobenetine has a monoisotopic molecular weight of 379.25 Da.
Dalzanemdor
go.drugbank.com/drugs/DB21549InvestigationalDalzanemdor has a monoisotopic molecular weight of 456.32 Da.
Cefovecin
go.drugbank.com/drugs/DB11505ExperimentalVet approvedHowever, these injectable agents can present long-lasting subtherapeutic concentrations after the resolution of infection. … The advantage of using injectable antibiotics is not missing a dose that can allow partially resistant microbes to recover during missed doses.